Hypothalamic growth hormone releasing factor deficiency following cranial irradiation.
AffiliationDepartment of Endocrinology, Chrisite Hospital, Manchester.
MetadataShow full item record
AbstractThe effect of synthetic human pancreatic tumour GH releasing factor (hp GRF1-44) on GH release has been studied in 10 patients with radiation-induced GH deficiency and four normal subjects. All 10 patients showed subnormal GH responses to both an ITT (median peak GH 3.2 mU/l) and to arginine stimulation (median peak GH 2.9 mU/l), although the remainder of pituitary function was intact. Following an acute intravenous bolus (100 micrograms) of hp GRF1-44, there was no GH response in two patients and a subnormal but definite GH response in a further four. The remaining four patients showed a significant GH response (median peak GH level 29 mU/l; range 22-57 mU/l) to hp GRF1-44, similar in magnitude and timing to that seen in the four normals. This strongly suggests that in these four subjects, the discrepancy in GH responses to hp GRF1-44, ITT and to arginine was a result of radiation-induced hypothalamic damage leading to a deficiency of endogenous GRF. The availability of synthetic hp GRF capable of stimulating GH secretion means that the distinction between hypothalamic and pituitary causes of GH deficiency will be of considerable therapeutic importance in the future.
CitationHypothalamic growth hormone releasing factor deficiency following cranial irradiation. 1984, 21 (5):483-8 Clin Endocrinol
- Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
- Authors: Lustig RH, Schriock EA, Kaplan SL, Grumbach MM
- Issue date: 1985 Aug
- Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
- Authors: Darzy KH, Thorner MO, Shalet SM
- Issue date: 2009 Feb
- Growth hormone response to GRF 1-44 in children following cranial irradiation for central nervous system tumors.
- Authors: Oberfield SE, Kirkland JL, Frantz A, Allen JC, Levine LS
- Issue date: 1987 Fall
- Radiation and neuroregulatory control of growth hormone secretion.
- Authors: Ogilvy-Stuart AL, Wallace WH, Shalet SM
- Issue date: 1994 Aug
- The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
- Authors: Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM
- Issue date: 2003 Jan